Decibel Cannabis Company Inc. cultivates, processes, and sells cannabis products in Canada. The company shows strong financial health with a gross margin of 50.6% and an EBITDA margin of 21.9%, indicating efficient operations. However, its return on equity (ROE) of 6.5% suggests limited profitability relative to shareholder equity. The current ratio of 2.44 indicates good liquidity, but a debt-to-equity ratio of 0.89 raises concerns about leverage. Overall, while Decibel demonstrates solid margins, its low ROE and moderate debt levels warrant caution.
Loading financial metrics...
Debt of $57.6M is 5.8x the company's cash position of $10.0M.
Company went from $9.0M profit to $-667K loss compared to last year.
Exceptional revenue growth of 26.4% YoY demonstrates strong market demand and competitive positioning.
Operating margin expanded by 5.0pp, demonstrating strong operational leverage.
Both gross margin (+1.7pp) and operating margin (+5.0pp) are expanding simultaneously, indicating the company is scaling profitably.
Strong liquidity position with current ratio of 2.4x.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q2 (June 30, 2026)